BRIEF published on 01/15/2026 at 11:50, 2 months 15 days ago Zürcher Kantonalbank's Disclosure on Avadel Pharmaceuticals Form 8.3 Irish Takeover Panel Securities Disclosure Zürcher Kantonalbank Avadel Pharmaceuticals
PRESS RELEASE published on 01/15/2026 at 11:45, 2 months 15 days ago Form 8.3 - Zürcher Kantonalbank: Avadel Pharmaceuticals plc Zürcher Kantonalbank discloses ownership of 0.04% of Avadel Pharmaceuticals plc shares as of 14-Jan-2026, as per Form 8.3 filing with the Irish Takeover Panel Form 8.3 Irish Takeover Panel Ownership Disclosure Zürcher Kantonalbank Avadel Pharmaceuticals Plc
BRIEF published on 01/14/2026 at 14:35, 2 months 16 days ago Zürcher Kantonalbank Discloses Position in Avadel Pharmaceuticals Ordinary Shares Disclosure Irish Takeover Panel Zürcher Kantonalbank Avadel Pharmaceuticals
PRESS RELEASE published on 01/14/2026 at 14:30, 2 months 16 days ago Form 8.3 - Zürcher Kantonalbank: Avadel Pharmaceuticals plc Zürcher Kantonalbank and subsidiaries disclosed 1.55% stake in Avadel Pharmaceuticals plc on 13th January 2026 Disclosure Irish Takeover Panel Stake Zürcher Kantonalbank Avadel Pharmaceuticals Plc
BRIEF published on 01/06/2026 at 12:50, 2 months 24 days ago Zürcher Kantonalbank Discloses Stake in Avadel Pharmaceuticals Form 8.3 Irish Takeover Panel Securities Disclosure Zürcher Kantonalbank Avadel Pharmaceuticals
PRESS RELEASE published on 01/06/2026 at 12:45, 2 months 24 days ago Form 8.3 - Zürcher Kantonalbank: Avadel Pharmaceuticals plc Zürcher Kantonalbank and subsidiaries disclose a 0.04% interest in Avadel Pharmaceuticals plc. Details of open stock-settled derivatives positions provided Disclosure Irish Takeover Panel Stock-settled Derivatives Zürcher Kantonalbank Avadel Pharmaceuticals Plc
BRIEF published on 01/05/2026 at 20:35, 2 months 25 days ago Zürcher Kantonalbank Discloses Position in Avadel Pharmaceuticals Form 8.3 Irish Takeover Panel Securities Holding Zürcher Kantonalbank Avadel Pharmaceuticals
PRESS RELEASE published on 01/05/2026 at 20:30, 2 months 25 days ago Form 8.3 - Zürcher Kantonalbank: Avadel Pharmaceuticals plc Zürcher Kantonalbank and subsidiaries disclosed a 1.02% interest in Avadel Pharmaceuticals plc shares on 2nd January 2026 Shares Disclosure Interests Zürcher Kantonalbank Avadel Pharmaceuticals Plc
BRIEF published on 01/05/2026 at 17:05, 2 months 25 days ago Zürcher Kantonalbank Discloses Position in Avadel Pharmaceuticals Form 8.3 Irish Takeover Panel Securities Disclosure Zürcher Kantonalbank Avadel Pharmaceuticals
PRESS RELEASE published on 01/05/2026 at 17:00, 2 months 25 days ago Form 8.3 - Zürcher Kantonalbank: Avadel Pharmaceuticals plc Zürcher Kantonalbank discloses 1.02% position in Avadel Pharmaceuticals plc as of 31st December 2025 following dealing activities Position Disclosure Zürcher Kantonalbank Avadel Pharmaceuticals Plc 1.02% Dealing Activities
Published on 03/31/2026 at 01:15, 6 hours 27 minutes ago Core Critical Metals Corp. Announces Filing of Amended and Restated LIFE Offering Document
Published on 03/30/2026 at 20:45, 10 hours 57 minutes ago Caledonia Mining Corporation Plc - Notification of Relevant Change to Significant Shareholder
Published on 03/30/2026 at 16:55, 14 hours 47 minutes ago Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy
Published on 03/30/2026 at 16:25, 15 hours 17 minutes ago CORRECTION: Mandela Dollar ("MUSD") Announced to Promote Mandela's Legacy of Financial Inclusion for Underserved Communities Across the World
Published on 03/31/2026 at 07:31, 11 minutes ago adesso SE publishes 2025 consolidated financial statements: Sales increased to EUR 1.47 billion (+14%) / EBITDA improved by 30% to EUR 123.6 million / Earnings per share EUR 2.83
Published on 03/31/2026 at 07:30, 11 minutes ago Masterflex releases its 2025 Annual Report – record results achieved once again – new momentum from growth projects
Published on 03/31/2026 at 07:30, 11 minutes ago PAL Next AG: Business Performance in 2025 in Line with Plan
Published on 03/31/2026 at 07:30, 11 minutes ago Nordex Group receives 42 MW order from Max Bögl in North Rhine-Westphalia, Germany
Published on 03/31/2026 at 07:30, 12 minutes ago Energiekontor AG: Energiekontor achieves solid Group earnings in the 2025 financial year and strengthens basis for further growth
Published on 03/30/2026 at 18:45, 12 hours 57 minutes ago ENGIE is expanding its power transmission activities in Brazil with the award of new concessions
Published on 03/30/2026 at 17:48, 13 hours 53 minutes ago Reporting on share buyback transactions carried out between March 23 and March 27, 2026
